ShareValue scores for FISCHER.NSE: Valuation 22, Quality 27, Growth 69, Health 41.

FISCHER.NSE
NSE

Fischer Medical Ventures Limited

₹37.27(-3.55%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

-7% to 11%
Valuation
22
Overvalued
Price vs Value
Quality
27
Weak
Business Strength
Growth
69
Moderate
Revenue & Earnings
Health
41
Moderate
Financial Stability
Momentum
53
Neutral
Price Trend

Company Details

About

Fischer Medical Ventures Limited engages in the manufacture, distribution, leasing, and maintenance of medical equipment in India and internationally. Its product portfolio includes magnetic resonance imaging (MRI) systems; preventive health kiosks; e-health access points; software solutions; cancer, TB screening, and handheld x-ray; spincare technology; nutraceuticals from plant extracts; mental health solutions; contactless screening solutions; and CT scan systems, as well as preventive diagnostic devices and ancillary medical instruments. The company was formerly known as Fischer Chemic Limited and changed its name to Fischer Medical Ventures Limited in March 2024. Fischer Medical Ventures Limited was incorporated in 1993 and is headquartered in Chennai, India.

Score Analysis

AI Investment Thesis

Data as of:Aug 18, 2026
|
Last calculated:Aug 18, 2026